SEOM clinical guidelines for the treatment of diffuse large B-cell lymphoma.
Diffuse large B-cell non-Hodgkin's lymphoma (LDCGB) is one of the best examples of chemotherapy curable malignant diseases. This "Oncoguía SEOM" summarizes the basic directions of staging and recommended treatment options. The staging study should be thorough and includes clinical, laboratory, diagnostic imaging and nuclear medicine. Treatment depends on patient characteristics and comorbidity and on disease extension and prognostic factors. In localized cases, chemoimmunotherapy (CHOP-R) of short duration, followed by involved-field irradiation is the preferred option. In advanced stages, the association of CHOP-like chemotherapy and Rituximab has been a major breakthrough in terms of cure rate. It is important do not forget the supportive treatment in these patients.
Gómez Codina
José
J
Servicio de Oncología Médica, Hospital Universitario La Fe, Valencia, Spain.
Sabín Domínguez
Pilar
P
Provencio Pulla
Mariano
M
Rueda Domínguez
Antonio
A
Isla Casado
Dolores
D
D000465:Algorithms; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy*; D008495:Medical Oncology / Q000379:methods* / Q000639:trends; D012955:Societies, Medical; D013030:Spain